Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626834 · ClinicalTrials.gov registry record · Phase 1
Vigabatrin Ph 1 Cocaine Interaction Study
A Phase 1 study of Cocaine Addiction, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00626834: Completed Phase 1 study of Cocaine Addiction, sponsored by National Institute on Drug Abuse (NIDA).
NCT00626834 is a Phase 1 study of Cocaine Addiction that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 24 participants, below the 83-participant average among 5 other Cocaine Addiction trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00626834, a Phase 1 study of Cocaine Addiction, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1 safety/tolerably study to determine if there are clinically significant interactions between oral vigabatrin (gamma vinyl-gamma-amino butyric acid; VGB) concurrent with intravenous (IV) cocaine infusions.
Conditions Studied
Interventions
- DRUG Matching placebo
- DRUG Vigabatrin
Study Locations (1)
Texas
- University of Texas Health Science Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
What the finished NCT00626834 record still lists
NCT00626834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 83-participant average among 5 other Cocaine Addiction trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Cocaine Addiction appearing as the primary indexed condition, and to 2 interventions - of which Matching placebo is the first listed.
NCT00626834 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00626834 about?
NCT00626834 is a clinical study titled "Vigabatrin Ph 1 Cocaine Interaction Study". This is a Phase 1 safety/tolerably study to determine if there are clinically significant interactions between oral vigabatrin (gamma vinyl-gamma-amino butyric acid; VGB) concurrent with intravenous (IV) cocaine infusions.
What is the current status of trial NCT00626834?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-02. Estimated completion is 2010-10.
What conditions does trial NCT00626834 study?
This clinical trial studies the following conditions: Cocaine Addiction.
What interventions are being tested in trial NCT00626834?
The interventions under investigation include: Matching placebo (DRUG), Vigabatrin (DRUG).
Who is sponsoring clinical trial NCT00626834?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00626834 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
COMPLETED · Phase 1
-
Integrative Meditation (IM) for Cocaine Addiction
COMPLETED · NA
-
Exercise as a Behavioral Treatment for Cocaine Dependence
COMPLETED · NA
-
Vigabatrin for the Treatment of Cocaine Dependency
COMPLETED · Phase 2
-
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia